Medication info
Tutustar Tablets 40/5 mg

Tutustar Tablets 40/5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Cosmax Pharma Co., Ltd.
Appearance
White or off-white rectangular tablet
Packaging
Domestic use - 30 tablets/Alu-Alu [10 tablets/Alu-Alu * 3]
Approval status
Active

MFDS item code 201708048 · Approved 2017.11.23 · Insurance code 055100160

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended, if possible, to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components, switching directly to this medicine may be considered as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. - 80/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or this medicine 40/10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams and 80/10 milligrams). ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section '3. Patients requiring cautious administration'). In older adults aged 75 years and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
Child dose
◦ Children: Administration of this medicine is not recommended because its safety and efficacy have not been established in pediatric patients aged 18 years or younger.

Ingredients

Manufacturer
Cosmax Pharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

For patients with essential hypertension, there may be cases where blood pressure is not adequately controlled using amlodipine or telmisartan alone. In such cases, co-administration of both medications can effectively lower blood pressure. Proper blood pressure control is crucial to reducing the risk of complications such as heart disease and stroke. Therefore, this medication is used for improving blood pressure control in patients with essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended, if possible, to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components, switching directly to this medicine may be considered as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. - 80/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or this medicine 40/10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams and 80/10 milligrams). ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section '3. Patients requiring cautious administration'). In older adults aged 75 years and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.

Child dose

◦ Children: Administration of this medicine is not recommended because its safety and efficacy have not been established in pediatric patients aged 18 years or younger.

Precautions

This medication can pose serious risks to the fetus, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be administered to patients with certain medical conditions or situations. For example, individuals with an allergy to the drug components, pregnant women or women who may become pregnant, nursing mothers, patients with severely impaired liver function, and those with serious heart issues should not take this medication. Caution should also be exercised in patients with primary aldosteronism or certain heart valve diseases, liver dysfunction, gastrointestinal disorders, renal vascular issues, renal failure, and elderly patients. Dose adjustments or close monitoring by a physician may be necessary. Common side effects of this medication include dizziness and peripheral edema, and while serious side effects are rare, any abnormal symptoms should prompt immediate consultation with a physician. Use of this medication should be avoided during pregnancy, and if planning to become pregnant or if already pregnant, alternatives should be discussed with a physician. Hypotension symptoms may occur during treatment, particularly in patients who are fluid or salt-constricted, necessitating caution and appropriate measures if hypotension arises. This medication poses a risk of elevated serum potassium levels, so periodic blood testing to monitor potassium levels should be conducted if combined with other medications that can increase potassium levels. Patients with impaired renal function should have regular checks of renal function and electrolyte status when taking this medication. Patients with heart disease should be cautious as this medication may increase the risk of myocardial infarction or angina; dose adjustments and monitoring are necessary. This medication may cause drowsiness or dizziness, so caution is advised when driving or operating hazardous machinery during treatment. Interaction with other medications is possible; therefore, any current medications should be disclosed to a physician or pharmacist, especially for combinations with specific heart medications, diuretics, anti-inflammatories, lithium, digoxin, etc. This medication is not recommended for children as safety and efficacy have not been established, and for the elderly, dosing should be adjusted to increase gradually for safety. In cases of overdose, symptoms such as hypotension, dizziness, and cardiac issues may occur, requiring immediate medical attention. This medication must be kept out of reach of children and it is important to open packaging only just before use to maintain product quality.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leucopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • altered mental status
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal symptoms
  • increased muscle tone
  • visual impairment
  • double vision
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic dermatitis
  • drug eruption
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • acute renal failure
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light to enter. It is advisable to store it at room temperature between 1 to 30 degrees Celsius. Proper storage can help maintain the drug's effectiveness over time.

Appearance and packaging

Appearance

White or off-white rectangular tablet

Package unit

Domestic use - 30 tablets/Alu-Alu [10 tablets/Alu-Alu * 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.